«Fabry Disease

Below is an extended Fabry Disease patents listing. Click here to return to the Fabry Disease main in depth entry.

Patents :
US Patent No.	Title
7232667	Keratinocyte growth factor-2 polynucleotides
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7294700	Anti-PRO846 antibodies
7297511	Interferon alpha: remodeling and glycoconjugation of interferon alpha
7307068	Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
7309716	Benzimidazoles useful as modulators of ion channels
7312344	Dimeric isoflavones
7319015	Methods and compositions for using alveolar macrophage phospholipase A2
7329490	Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
7329749	Piperazinylcarbonylquinolines and -isoquinolines
7335681	Amino ceramide-like compounds and therapeutic methods of use
7285623	PRO337 polypeptides
7282222	Methods and compositions for directing cells to target organs
7279553	PRO1083 polypeptides
7232670	Targeting proteins to cells expressing mannose receptors via expression in insect cells
7241442	Method for producing proteins suitable for treating lysosomal storage disorders
7256002	Screening for neurotoxic amino acid associated with neurological disorders
7264926	Nucleoside Phosphatase
7265084	Glycopegylation methods and proteins/peptides produced by the methods
7265085	Glycoconjugation methods and proteins/peptides produced by the methods
7267965	Means and methods for regulating gene expression
7267966	Complexity management and analysis of genomic DNA
7268123	Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them
7276475	Remodeling and glycoconjugation of peptides
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7339049	Polymorphisms in human mitochondrial DNA
7384632	Agonist anti-trk-C monoclonal antibodies
7396811	Subcellular targeting of therapeutic proteins
7399584	Method of comparing a target nucleic acid and a reference nucleic acid
7399613	Sialic acid nucleotide sugars
7399638	Prediction method for lipidosis
7399740	Poly-Glu,Tyr for neuroprotective therapy
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7407936	Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
7407973	Use of pirfenidone in therapeutic regimens
7407976	Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
7381709	Method of expressing foreign gene in kidney
7378492	CD40-related receptor that binds CD40L
7378231	Diagnosis of lysosomal storage disorders using saposins and other markers
7341720	Targeting of glycoprotein therapeutics
7345025	Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
7345065	Methods and compositions for alleviating pain
7348000	Therapeutic compositions and methods of treating glycolipid storage related disorders
7358086	Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
7359748	Apparatus for total immersion photography
7361481	Diagnosis of lysosomal storage disorders using saposins and other markers
7371366	GlcNAc phosphotransferase of the lysosomal targeting pathway
7371836	PRO526 nucleic acids
7375198	Modified nucleic acid probes
7410659	Methods for the treatment of peripheral neural and vascular ailments

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.